Female leaders join with COO ‘proud of team we’re building’


Kathryn Corzo took up the role of chief operating officer (COO) at synthetic biology company in November.

She joined, whose expertise combines coding with biology to provide new human cells for research, she had been a partner at Takeda Ventures Inc, and head of oncology cell therapy development at Takeda Pharmaceuticals. She also served on Takeda’s R&D management committee, was a member of Takeda’s oncology leadership team and served on the board of directors for Maverick Therapeutics which was acquired by Takeda in 2021.

Read the full article here.